DQGlyco identified multiple unique N-glycopeptides, quantified glycopeptide changes, and explored the link between gut microbiome and brain protein functions.
Ministers have generated policies to protect soil, forests, bees, fish, cows, oceans, big rivers, you name it. But what about the microbes?
Bacterial metabolites such as inosine could be used as a therapy to strengthen infant immunity after early microbiota disruption.
N-acyl lipids are important, overlooked molecules shaped by diet and gut microbes.
With a strategic loan from the European Investment Bank, the French biotech doubles down on its mission to bring microbiome ecosystem therapies to market for patients battling blood cancers.
Fiber can influence how well bacteria from a fecal microbiota transplant successfully settle and grow in a person’s gut.
Targeting the gut microbiota could help predict, prevent or reduce chemotherapy-related toxicity.
Professor Ruggiero Francavilla, pediatric gastroenterologist at the Polyclinic of Bari (Italy), offers a preview of his upcoming talk at the 10th International Congress of Probiotics, Prebiotics, and Postbiotics in Pediatrics.
A unique partnership between Yakult and Nature Portfolio to build a global community of microbiome pioneers.
Region-specific microbial transplants may be safer and more effective than standard fecal microbiota transplants.
